state Massachusets hospital covid-19 testing state Massachusets

Hoth Therapeutics forms JV to develop Covid-19 vaccine

Reading now: 170
www.pharmaceutical-technology.com

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Hoth Therapeutics has collaborated with Voltron Therapeutics to establish a joint venture (JV), HaloVax, for preclinical studies of vaccine candidates against Covid-19.

Vaccine candidates come from VaxCelerate self-assembling vaccine (SAV) platform, exclusively licensed by Voltron from the Massachusetts General Hospital (MGH)’s Vaccine and Immunotherapy Center (VIC).

Hoth Therapeutics and Voltron will work together to explore and develop SAV technology to fight the novel coronavirus infection.

VaxCelerate platform enables rapid development and pre-clinical testing of a new vaccine against specific pathogen targets. According to Hoth Therapeutics, the

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA